Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection - Top-Institutions - MDSpire

Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection

  • By

  • Xianjun Rao

  • Guodong Huang

  • Jiaxuan Li

  • Chunyu Wu

  • Min Yang

  • Xianfeng Rao

  • Zixing Qian

  • Liji Chen

  • Yang Yang

  • Wei Wei

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Asian Cancer Research Group
    Asian Cancer Research Group

    N/A, N/A

    Key Differentiators

    • Oncology

  • #2

    Center for Personalized Cancer Therapy at Moores Cancer Center, University of California, San Diego
    Center for Personalized Cancer Therapy at Moores Cancer Center, University of California, San Diego

    San Diego, California

    Key Differentiators

    • Oncology

  • #3

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #5

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

Original Source(s)

Optimizing immunotherapy in advanced gastric cancer: established and emerging biomarkers for precision patient selection

  • by Xianjun Rao, Guodong Huang, Jiaxuan Li, Chunyu Wu, Min Yang, Xianfeng Rao, Zixing Qian, Liji Chen, Yang Yang, Wei Wei

  • July 1, 2026

Related Content

Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis

Case Report: Trazodone as a possible treatment for psychiatric adverse events related to ALK inhibitors